Pre-surgical Aerobic Exercise for Cancer
Trial Summary
What is the purpose of this trial?
The purpose of this study is to find the safest level of aerobic training for people about to undergo surgery for their cancer, and to learn what effects, if any, aerobic exercise has on these patients and the outcomes of their cancers. This part of the study (Phase 0) will evaluate the feasibility and quality of at-home exercise and assessment procedures and find out whether study participants are willing to practice continuous lifestyle monitoring using apps and electronic devices. Phase 1a will compare the effects and feasibility of six different doses of aerobic exercise and will continue evaluating the quality of at-home study procedures, which includes the use of continuous lifestyle monitoring through apps and electronic devices. In order to facilitate completion of the phase 1a component, we will backfill the 90, 225, and 300 mins/wk dosing cohorts with at least 4 patients in each dose cohort.
Research Team
Lee W. Jones, PhD
Principal Investigator
Memorial Sloan Kettering Cancer Center
Eligibility Criteria
This trial is for adults over 18 with a BMI ≤ 40 who have been diagnosed with early-stage breast, endometrial, or prostate cancer and are scheduled for surgery. They should not be doing more than minimal structured exercise weekly and must be willing to follow study procedures including at-home exercise and lifestyle monitoring.Inclusion Criteria
Exclusion Criteria
Treatment Details
Interventions
- Treadmill Walking (Behavioural Intervention)
Find a Clinic Near You
Who Is Running the Clinical Trial?
Memorial Sloan Kettering Cancer Center
Lead Sponsor
Lisa M. DeAngelis
Memorial Sloan Kettering Cancer Center
Chief Medical Officer since 2021
MD from Columbia University
Selwyn M. Vickers
Memorial Sloan Kettering Cancer Center
Chief Executive Officer since 2022
MD from Johns Hopkins University
Vanderbilt University
Collaborator
Robert L. Caldwell
Vanderbilt University
Chief Executive Officer since 2003
PhD in Pathology from Vanderbilt University
Rick Wright
Vanderbilt University
Chief Medical Officer since 2023
MD from Washington University School of Medicine in St. Louis